on SkinIntegra
Clinical Data Shows That SkinIntegra Works Faster Than Urea-40% Cream on Pedal Fissures
LOS ANGELES, CA / ACCESSWIRE / August 8, 2024 / SkinIntegra, an emerging therapeutic skin care company, announced today that a randomized, double-blind clinical trial was conducted by The Western School College of Podiatric Medicine. The trial aimed to evaluate the comparative efficacy of Urea-40 and SkinIntegra in addressing pedal fissures.
Results showed that SkinIntegra's Rapid Crack Repair Cream significantly improved dryness and cracking faster than urea-40% cream, with less irritation after extended use. Erika Tazberik, CTO and Co-Founder of SkinIntegra, stated, "This new clinical data supports that our product may offer a more efficacious and tolerable alternative to urea-40 for managing pedal fissures."
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SkinIntegra news